
We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.
Version: 20241125
We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.